Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 430-434

  Wang, Wei ^b   Macaulay, Robert J B ^a,b  

^a HSB B419 ^*  (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MANUMYCIN A; MEVINOLIN; MITOGENIC AGENT; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOPRENYLATION; MEDULLOBLASTOMA; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MEDULLOBLASTOMA; POLYENES; POLYUNSATURATED ALKAMIDES; PROTEIN ISOPRENYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); TUMOR CELLS, CULTURED;

EID: 0033041695     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<430::AID-IJC17>3.0.CO;2-9     Document Type: Article

References (34)

1. BANSAL, N., HOULE, A.G. and MELNYKOVYCH, G., Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T-cell derived human acute leukemia lines (CEM). Leukemia Res., 13, 875-882 (1989).
2. BARBACID, M., ras genes. Ann. Rev. Biochem., 56, 779-827 (1987).
3. BUCHKOVICH, K., The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58, 1097-1105 (1989).
4. DIMITROULAKOS, J., PIENKOWSKA, M., SQUIRE, J., ZIELENSKA, M. and YEGER, H., Differential display of mRNAs using PCR (DD-PCR) to identify genes involved in the growth and differentiation of human neuroblastomas [abstract]. Brain Pathol., 4, 427 (1994).
5. GUTIERREZ, L., MAGEE, A.I., MARSHALL, C.J. and HANCOCK, J.F., Posttranslational processing of p21 ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J., 8, 1093-1098 (1989).
6. HALE, A.J., SMITH, C.A., SUTHERLAND, L.C., STONEMAN, V.E., LONGTHORNE, V.L., CULHANE, A.C. and WILLIAMS, G.T., Apoptosis: molecular regulation of cell death. Europ. J. Biochem., 236, 1-26 (1996).
7. HANCOCK, J.F., MAGEE, A.I., CHILDS, J.E. and MARSHALL, C.J., All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177 (1989).
8. HARA, M., AKASAKA, K., AKINAGA, S., OKABE, M., NAKANO, H., GOMEZ, R., WOOD, D., UH, M. and TAMANOI, F., Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc. nat. Acad. Sci. (Wash.), 90, 2281-2285 (1993).
9. IOLASCON, A., LANIA, A., BADIALI, M., PESSION, A., SAGLIO, G., GIANGASPERO, F., MIRAGLIA, D.G.E., PERROTTA, S. and CUTILLO, S., Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues. Med. Pediatr. Oncol., 19, 240-245 (1991).
10. JONES, K.D., COULDWELL, W.T., HINTON, D.R., SU, Y., HE, S., ANKER, L. and LAW, R.E., Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. biophys. Res. Comm., 205, 1681-1687 (1994).
11. KELES, G.E., BERGER, M.S., SRINIVASAN, J., KOLSTOE, D.D., BOBOLA, M.S. and SILBER, J.R., Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol. Res., 7, 493-503 (1995).
12. 1 to multiple cell cycles by lovastatin. Cancer Res., 51, 3602-3609 (1991).
13. KHOSRAVI, F.R., COX, A.D., KATO, K. and DER, C.J., Protein prenylation: key to ras function and cancer intervention? Cell Growth Differentiation, 3, 461-469 (1992).
14. KOHL, N.E., MOSSER, S.D., DE SOLMS, S.J., GIULIANI, E.A., POMPLIANO, D.L., GRAHAM, S.L., SMITH, R.L., SCOLNICK, E.M., OLIFF, A. and GIBBS, J.B., Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor [see comments]. Science, 260, 1934-1937 (1993).
15. KOHL, N.E. AND 14 OTHERS, Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. nat. Acad. Sci. (Wash.), 91, 9141-9145 (1994).
16. LEBOWITZ, P.F., DAVIDE, J.P. and PRENDERGAST, G.C., Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol. cell. Biol., 15, 6613-6622 (1995).
17. MACAULAY, R.J.B., MCGREGOR, C. and KILBURN, M.P.B., Lack of co-expression of p21ras, Bcl-2 and p53 in medulloblastoma [abstract]. J. Neuropathol. exp. Neurol., 55, 626 (1996).
18. MACAULAY, R.J.B., WANG, W., DIMITROULAKOS, J., BECKER, L. and YEGER, H., Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro. J. Neurooncol., 42, 1-11 (1999).
19. MAGEE, A.I., GUTIERREZ, L., MCKAY, I.A., MARSHALL, C.J. and HALL, A., Dynamic fatty acylation of p21N-ras. EMBO J., 6, 3353-3357 (1987).
20. MALTESE, W.A., DEFENDINI, R., GREEN, R.A., SHERIDAN, K.M. and DONLEY, D.K., Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. clin. Invest., 76, 1748-1754 (1985).
21. MANGUES, R., CORRAL, T., KOHL, N.E., SYMMANS, W.F., LU, S., MALUMBRES, M., GIBBS, J.B., OLIFF, A. and PELLICER, A., Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice. Cancer Res., 58, 1253-1259 (1998).
22. MARSHALL, C.J., MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Develop., 4, 82-89 (1994).
23. 2-M enrichment in A549 cells. Cancer Res., 57, 1846-1850 (1997).
24. MITSUZAWA, H. and TAMANOI, F., In vivo assays for farnesyltransferase inhibitors with Saccharomyces cerevisiae. Methods Enzymol., 250, 43-51 (1995).
25. NAGASE, T., KAWATA, S., TAMURA, S., MATSUDA, Y., INUI, Y., YAMASAKI, E., ISHIGURO, H., ITO, T. and MATSUZAWA, Y., Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor: a preferential suppression of ras farnesylation. Int. J. Cancer, 65, 620-626 (1996).
26. PEREZ, S.D. and MOLLINEDO, F., Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem. biophys. Res. Comm., 199, 1209-1215 (1994).
27. SEPP-LORENZINO, L., MA, Z., RANDS, E., KOHL, N.E., GIBBS, J.B., OLIFF, A. and ROSEN, N., A peptidomimetic inhibitor of farnesyl: protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res., 5, 5302-5309 (1995).
28. 1 block in p53 wild type tumor cells. J. biol. Chem., 273, 20243-20251 (1998).
29. SUMI, S., BEAUCHAMP, R.D., TOWNSEND, C.J., UCHIDA, T., MURAKAMI, M., RAJARAMAN, S., ISHIZUKA, J. and THOMPSON, J.C., Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology, 103, 982-989 (1992).
30. TOBERT, J.A., HITZENBERGER, G., KUKOVETZ, W.R., HOLMES, I.B. and JONES, K.H., Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis, 41, 61-65 (1982).
31. VINCENT, T.S., WULFERT, E. and MERLER, E., Inhibition of growth factor signaling pathways by lovastatin. Biochem. biophys. Res. Comm., 180, 1284-1289 (1991).
32. 1 to S phase transition in mouse fibroblasts. Oncogene, 13, 1991-1999 (1996).
33. WANG, W. and MACAULAY, R.J.B., Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines. Canad. J. Neurol. Sci., (Accepted for publication).
34. WHYTE, D.B., KIRSCHMEIER, P., HOCKENBERRY, T.N., NUNEZ, O.I., JAMES, L., CATINO, J.J., BISHOP, W.R. and PAI, J.K., K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. biol. Chem., 272, 14459-14464 (1997).